1690O NKT2152, a Novel Oral HIF-2α Inhibitor, in Participants (pts) with Previously Treated Advanced Clear Cell Renal Carcinoma (accrcc): Preliminary Results of a Phase I/II Study

E. Jonasch,B.A. McGregor,P. Msaouel, T. Logan, E.T. Hall,M.A. Bilen,G.S. Falchook,B. Shuch,Y. Zakharia, R. Hauke,M. Gordon, A-R. Naqash,C.W. Ryan, R. Srinivasan, J. Xiao, W. Sun, M. Esguerra, G. Lu, J. Lager,T.K. Choueiri

Annals of Oncology（2024）

Cited 0|Views0

AI Read Science

Must-Reading Tree

Example

Generate MRT to find the research sequence of this paper

Chat Paper

Summary is being generated by the instructions you defined